Steven A. Lisi Acquires 100,000 Shares of Beyond Air, Inc. (NASDAQ:XAIR) Stock

Beyond Air, Inc. (NASDAQ:XAIR) CEO Steven A. Lisi acquired 100,000 shares of the business’s stock in a transaction dated Wednesday, August 14th. The shares were acquired at an average cost of $0.39 per share, with a total value of $39,000.00. Following the acquisition, the chief executive officer now directly owns 1,722,785 shares of the company’s stock, valued at approximately $671,886.15. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Beyond Air Price Performance

Shares of Beyond Air stock opened at $0.47 on Friday. The stock has a market capitalization of $21.71 million, a price-to-earnings ratio of -0.26 and a beta of -0.10. The company has a fifty day moving average of $0.70 and a 200-day moving average of $1.23. Beyond Air, Inc. has a 52-week low of $0.36 and a 52-week high of $3.35. The company has a debt-to-equity ratio of 0.54, a quick ratio of 3.61 and a current ratio of 3.80.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.12. The business had revenue of $0.68 million during the quarter, compared to analyst estimates of $0.72 million. Beyond Air had a negative net margin of 5,197.76% and a negative return on equity of 203.12%. During the same period in the prior year, the business posted ($0.45) earnings per share. Equities research analysts expect that Beyond Air, Inc. will post -1.01 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on XAIR. Roth Mkm reissued a “buy” rating and issued a $2.00 price target on shares of Beyond Air in a research note on Friday. Truist Financial cut their target price on shares of Beyond Air from $10.00 to $8.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Piper Sandler lowered their price target on Beyond Air from $3.50 to $1.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. BTIG Research cut Beyond Air from a “buy” rating to a “neutral” rating in a report on Tuesday, June 25th. Finally, Roth Capital upgraded Beyond Air to a “strong-buy” rating in a research report on Friday. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $3.67.

Institutional Investors Weigh In On Beyond Air

Institutional investors have recently bought and sold shares of the stock. Keel Point LLC purchased a new position in Beyond Air in the 4th quarter worth approximately $30,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Beyond Air in the second quarter worth approximately $47,000. Rosalind Advisors Inc. bought a new position in shares of Beyond Air in the first quarter worth approximately $1,572,000. Gendell Jeffrey L increased its stake in shares of Beyond Air by 2.8% in the fourth quarter. Gendell Jeffrey L now owns 1,120,297 shares of the company’s stock worth $2,196,000 after buying an additional 30,000 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Beyond Air by 5.0% during the 1st quarter. Vanguard Group Inc. now owns 1,399,298 shares of the company’s stock valued at $2,435,000 after buying an additional 66,224 shares during the last quarter. 31.50% of the stock is currently owned by hedge funds and other institutional investors.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.